Pliant Therapeutics, Inc.
PLRXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $53.47M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.88$1.95
- Volume (live)
- -
- Avg. volume (3M)
- 402.91K
Pliant Therapeutics (PLRX) Stock Price & Financial Analysis
Pliant Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.83 - $0.88 |
|---|---|
| 52-Week High | $1.95 |
| 52-Week Low | $0.88 |
| Open | $0.87 |
| Volume (last close) | 446.82K |
| Average Volume (3M) | 402.91K |
| 50-Day MA | $1.08 |
|---|---|
| 200-Day MA | $1.18 |
| 1-Year Change | −50.55% |
| Market Cap | 53.47M |
|---|---|
| Shares Outstanding | 61.92M |
| Price to Book (P/B) | 0.36 |
| EV/EBITDA | -0.64 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Pliant Therapeutics at a Glance
As of the Oct 23, 2026 close, Pliant Therapeutics (PLRX) has a market capitalization of $53.47M.
As of its latest reported balance sheet, it holds $24.88M in cash and securities against $28.74M of debt, a net debt position of $3.86M.
Pliant Therapeutics does not currently pay a dividend.
The share price is down 50.6% over the past year. At $0.86 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.88 to $1.95, below its 200-day moving average of $1.18.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $2.00, 131.6% above the Oct 23, 2026 close.
Frequently Asked Questions About Pliant Therapeutics
What is the current stock price for PLRX?
As of the Oct 23, 2026 close, PLRX stock trades at $0.86. The 52-week range is $0.88–$1.95, with a day range of $0.83–$0.88.
What is the P/E ratio for PLRX?
The P/E ratio (Price-to-Earnings) for PLRX is shown in the Key Statistics section. This valuation metric helps compare Pliant Therapeutics, Inc. to industry peers.
Does PLRX pay dividends?
Pliant Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PLRX?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for PLRX is Hold. The average 12-month price target is $2.00, a 131.6% upside from the Oct 23, 2026 close of $0.86.
What is the market cap of PLRX?
As of the Oct 23, 2026 close, Pliant Therapeutics's market capitalization is $53.5M, classifying it as a micro-cap company. Pliant Therapeutics operates in the Healthcare sector within the Biotechnology industry.